European Lithium’s Greenland Gamble: A €37 Million Gap Could Decide the Fate of the Tanbreez Rare
European Lithium finds itself walking a tightrope. The planned merger with NASDAQ-listed Critical Metals Corp — a deal…
Novo Nordisk’s Pill Gamble: How Oral Wegovy Could Reshape the Obesity Market
The obesity drug arena is undergoing a fundamental recalibration. Volume is exploding, but pricing power is eroding. At…
Novo Nordisk’s Price War and AI Gamble to Defend Market Crown
Novo Nordisk slashes U.S. drug prices up to 50% by 2027 and partners with OpenAI to counter Eli…
Novo Nordisk’s Subscription Gamble Meets a Formidable New Rival
Novo Nordisk shares fall 50% from highs as Eli Lilly’s oral GLP-1 pill challenges Wegovy. The firm launches…